- Home
- MEDP vs CHRW Comparison
MEDP vs CHRW Comparison
Compare MEDP & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- CHRW
- Stock Information
- Founded
- MEDP 1992
- CHRW 1905
- Country
- MEDP United States
- CHRW United States
- Employees
- MEDP N/A
- CHRW N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- CHRW Oil Refining/Marketing
- Sector
- MEDP Health Care
- CHRW Consumer Discretionary
- Exchange
- MEDP Nasdaq
- CHRW Nasdaq
- Market Cap
- MEDP 13.4B
- CHRW 17.7B
- IPO Year
- MEDP 2016
- CHRW 1997
- Fundamental
- Price
- MEDP $585.14
- CHRW $152.15
- Analyst Decision
- MEDP Hold
- CHRW Buy
- Analyst Count
- MEDP 12
- CHRW 22
- Target Price
- MEDP $465.18
- CHRW $137.86
- AVG Volume (30 Days)
- MEDP 324.1K
- CHRW 1.8M
- Earning Date
- MEDP 10-22-2025
- CHRW 10-29-2025
- Dividend Yield
- MEDP N/A
- CHRW 1.63%
- EPS Growth
- MEDP 25.36
- CHRW 70.68
- EPS
- MEDP 14.32
- CHRW 4.94
- Revenue
- MEDP $2,358,373,000.00
- CHRW $16,504,785,000.00
- Revenue This Year
- MEDP $21.48
- CHRW N/A
- Revenue Next Year
- MEDP $11.90
- CHRW $3.07
- P/E Ratio
- MEDP $40.86
- CHRW $30.79
- Revenue Growth
- MEDP 13.88
- CHRW N/A
- 52 Week Low
- MEDP $250.05
- CHRW $84.68
- 52 Week High
- MEDP $625.00
- CHRW $158.70
- Technical
- Relative Strength Index (RSI)
- MEDP 57.97
- CHRW 66.32
- Support Level
- MEDP $573.07
- CHRW $149.08
- Resistance Level
- MEDP $609.13
- CHRW $153.89
- Average True Range (ATR)
- MEDP 16.64
- CHRW 4.12
- MACD
- MEDP -3.57
- CHRW 0.37
- Stochastic Oscillator
- MEDP 38.72
- CHRW 79.89
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.